Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. - Wikidata - awgldk - TriplyDB

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

http://www.wikidata.org/entity/Q34619192

about

Paraneoplastic neurological syndromes Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary RNA protein interaction in neurons Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia Autoimmune encephalopathies.Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease.Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma.Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.Ocular flutter as the presenting sign of lung adenocarcinoma Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.RNA Structures as Mediators of Neurological Diseases and as Drug Targets.Immunotherapy for paraneoplastic neurological disorders.Autoantigens: the critical partner in initiating and propagating systemic autoimmunity.Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.Paraneoplastic syndromes of the CNS.Enteric autoantibodies and gut motility disorders.Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.Movement disorders in paraneoplastic and autoimmune disease.Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma Neurological paraneoplastic syndromes.Anti-ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI.Paraneoplastic encephalomyelopathies: pathology and mechanisms.Neural antigen-specific autoimmune disorders.RNA binding proteins: a common denominator of neuronal function and dysfunction.Anti-Ri antibody associated small cell lung carcinoma.Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

P2860

Q21093169-B07ADDC8-D1C8-4048-B0F1-0330E9291213 Q22008829-E8D23D54-621D-4A0E-BE71-205639192F78 Q24602799-49D9F305-7F2B-4182-A864-EB1FB7B467B1 Q24646213-E89780C4-6429-4627-A2F6-EA1DE9029B3B Q24799005-3F4CFAF8-7C50-4872-8069-BDF6D2A82D19 Q24799120-70212C58-C31A-4EE6-BB37-5E0F4C84129A Q27001674-325AAB8C-D4CD-418B-83A9-8D5E255BD45F Q28080791-0C88636A-4934-4600-A6EC-785F6D282972 Q28513858-F2C46BA3-FA4E-47EE-B779-749A38F6D2F6 Q30389491-0292B34F-0969-4229-A692-AF942BD2CFE6 Q30587642-457B7C4E-4EEE-4BC3-AFC2-F1E72B4AE0A2 Q33591377-531396F4-75B0-4E12-92B4-ED277566A340 Q33600142-52CA21EA-8972-4728-9E83-43CA856D5F35 Q33732699-61411549-930E-44DB-916B-409E4429EB18 Q33946117-FDC549C9-1762-4860-871B-6984DDD20AA2 Q33997937-6D388718-FA06-4762-838F-7FCB16A00E42 Q34502931-597F84F5-3F02-4AC9-A8E0-9BCA3C4EE88A Q34911466-7E256FEA-3961-4398-8864-F19ECB456DD8 Q35476892-C0F606E6-E672-4F88-A415-296E26A30100 Q35868044-DB26CB66-BB32-4560-BB24-A731A334FA38 Q36273401-948E60BD-5321-4719-8298-4C1B1B4B3131 Q36388671-95FED9C7-DE19-48DC-8A60-004666C3B3C4 Q36403275-3A55653E-A893-4EDC-B04D-6836531851C7 Q36459516-173C2062-BA22-4A05-BF9F-331774364242 Q36519461-5EC8769A-AB23-4459-8856-9D5A3A0B5579 Q36631871-F205B5F9-FFF4-44F4-B069-E3498F324DF9 Q36750462-F4A81772-0CE9-457B-9760-C1465A7F31E0 Q36812520-69029E3D-F572-45E8-83D2-812F78E6FF81 Q36896885-C571D465-8A48-4B32-876D-3ACD67B1DC1D Q36993609-C62C4719-F819-4FC5-8345-DDC9324520CD Q37120552-9ADECA81-821A-454D-AFF9-7E08D515A014 Q37214732-7F4B4AFF-F1C2-49C9-A491-308610810D5E Q37384608-8017353C-6064-42EF-B27B-00BF3C40B6B8 Q37936924-A629260C-FF7D-42F7-A0CB-8E6EA00C3066 Q38020960-6B392D5A-C3BB-4A18-9DA4-E0CB95459CC3 Q38222976-B7803EE9-FD78-46DF-96CB-66B30006568D Q38718858-00E3C387-8741-4572-9D06-9AB0F48FFDC2 Q38726369-DF65FB16-D4A8-4403-AA24-C1B3D3CC0251 Q39225440-FF0F1497-79CE-4D37-ABFA-D91B6A4B600B Q39399892-F1A13D6B-4613-461A-813A-8BD1F6C22095

P2860

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

http://www.wikidata.org/entity/Q34619192

description

1991 nî lūn-bûn

@nan

1991 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի մարտին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@ast

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@en

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@nl

type

label

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@ast

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@en

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@nl

prefLabel

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@ast

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@en

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

@nl

P1433

Q34619192-6C875D1B-0E14-48A0-AEB0-EFCE6F8C02A8

P1476

Q34619192-8AA9D752-C8C7-48C7-A706-B551949F670D

P2093

Q34619192-078A5B3A-5C7B-4D70-9A13-575F25CC21C8

Q34619192-0C55B33C-523D-4654-A8BD-D4E375B8E392

Q34619192-114B390F-DA28-4A90-A472-C8087B049038

Q34619192-5A501F27-3D8D-409D-9801-1DBB56BDE676

Q34619192-60C97BE8-300E-4DF8-9A34-BDFC52EF2363

Q34619192-937BFBD8-CB72-4CE9-9CB3-AD85CA22BE18

Q34619192-CB48D961-9EF4-48E5-BEC0-FD7E8248ED6B

Q34619192-DD2C0289-2E42-4BED-BEBE-A288BA5B15C7

Q34619192-F37BC88E-0926-464D-9858-5FB6137190FB

P2860

Q34619192-1276A47F-CDC6-45BA-9960-10F06B6FAAB2

Q34619192-29CC8E57-746C-4B3F-BAE2-F9E02A9922A8

Q34619192-4C193A12-ABF7-439B-A547-757EC8860CD0

Q34619192-60E89CFE-61FA-4938-9146-9092D27DD6F1

Q34619192-6F6B80E2-F868-49E2-9A73-F98BFC558E5A

Q34619192-977A8CF1-3A48-4ADE-8CA9-8613FAC2204D

Q34619192-A77A469E-2E68-455A-9E0E-2F0327B497AB

Q34619192-AE4FD034-8E99-4B96-ACC8-EBDB4E8E6F08

Q34619192-F92D6D12-5903-434E-A6F2-9A69C2C2A851

P304

Q34619192-A0C59842-20B2-4DC6-BA72-8C19A36D7693

P31

Q34619192-ED66735F-4969-47E4-80C3-1F3BA68EDAFF

P356

Q34619192-A7C51271-C764-4CD3-B370-1505C4594190

P433

Q34619192-B9F823C2-D7A2-4EE1-BA9C-9A6784B32678

P478

Q34619192-D1C641CA-B4BB-4C13-A22C-D57D278DDDCE

P50

Q34619192-C666207A-80D8-496A-A039-3E7EA3F70757

P577

Q34619192-B9C14AB2-D2C0-471F-911E-54A8613815C3

P698

Q34619192-6A38A4C2-F377-472B-953C-E1F5CAFCAE2C

P921

Q34619192-60BBF4E9-F628-45BC-9CE6-046C2D051C82

P356

P1433

Annals of Neurology

P1476

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer

@en

P2093

Biran H

http://www.w3.org/2001/XMLSchema#string

Ferziger R

http://www.w3.org/2001/XMLSchema#string

Glantz MJ

http://www.w3.org/2001/XMLSchema#string

Jaeckle KA

http://www.w3.org/2001/XMLSchema#string

Lesser M

http://www.w3.org/2001/XMLSchema#string

Luque FA

http://www.w3.org/2001/XMLSchema#string

Rosenblum MK

http://www.w3.org/2001/XMLSchema#string

Schold SC Jr

http://www.w3.org/2001/XMLSchema#string

Wray SH

http://www.w3.org/2001/XMLSchema#string

P2860

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms.

A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.

Opsoclonus in adults. Report of three cases and review of the literature.

Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature.

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Opsoclonus: Its clinical value.

Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome.

Opsoclonus, occult carcinoma, and chemical pathology in dentate nuclei.

P304

241-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410290303

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

1991-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2042940

http://www.w3.org/2001/XMLSchema#string

P921